These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20976878)

  • 1. [Evaluation of the safety and efficacy of cefditoren pivoxil fine granules for pediatric use in pediatric patients with acute otitis media].
    Kawamata S; Yamada H; Sato Y; Sasagawa Y; Iwama Y; Matumoto M
    Jpn J Antibiot; 2010 Jun; 63(3):207-23. PubMed ID: 20976878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Causative organisms of acute otitis media and acute sinusitis in children and their susceptibility of oral beta-lactam antibiotics].
    Takenaka M; Morikawa Y; Nakagawa T; Takashima T; Haruta T; Tsuji T
    Jpn J Antibiot; 1999 Feb; 52(2):162-71. PubMed ID: 10221181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of cefditoren pivoxil in the treatment of acute otitis media due to benzylpenicillin-insensitive Streptococcus pneumoniae].
    Sugita R; Deguchi K; Kimura S; Harada S; Fujimaki Y; Watanabe H; Naito M; Nomura T; Tanaka M; Komatsu N; Shimizu K; Yoshida Y; Okano K
    Jpn J Antibiot; 1996 Apr; 49(4):386-98. PubMed ID: 8786629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the safety and efficacy of cefditoren pivoxil fine granules for pediatric use in pediatric patients with laryngopharyngitis and tonsillitis caused by Streptococcus pyogenes].
    Kawamata S; Yamada H; Sato Y; Sasagawa Y; Iwama Y; Matumoto M
    Jpn J Antibiot; 2010 Aug; 63(4):299-311. PubMed ID: 21298863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic, bacteriological and clinical studies on cefditoren pivoxil in children].
    Tajima T; Kobayashi M; Negishi S; Nishimura S; Yoshida A; Kudo S; Gondou M; Nakayama T; Abe T
    Jpn J Antibiot; 1993 Jul; 46(7):589-95. PubMed ID: 8371494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic, bacteriological and clinical evaluation of cefditoren pivoxil in pediatrics].
    Iwai N; Nakamura H; Miyazu M; Watanabe Y
    Jpn J Antibiot; 1994 Feb; 47(2):181-94. PubMed ID: 8151911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of safety and efficacy of tebipenem pivoxil granules for pediatric in pneumonia, otitis media and sinusitis].
    Kataoka H; Kasahara H; Sasagawa Y; Matsumoto M; Shimada S
    Jpn J Antibiot; 2016 Feb; 69(1):53-76. PubMed ID: 27290830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children.
    Piglansky L; Leibovitz E; Raiz S; Greenberg D; Press J; Leiberman A; Dagan R
    Pediatr Infect Dis J; 2003 May; 22(5):405-13. PubMed ID: 12792379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field].
    Toyonaga Y; Ishihara T; Sano T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1993 Jul; 46(7):604-28. PubMed ID: 8371496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinicobacteriologic study on clavulanic acid/amoxicillin in pediatric acute otitis media].
    Sugita R; Harada S; Deguchi K; Fujimaki Y; Naito M; Komatsu N; Nomura T; Okano K; Tanaka M; Shimizu K; Watanabe H; Kimura S; Yoshida Y; Senba T; Uchida T
    Jpn J Antibiot; 1999 Oct; 52(10):595-612. PubMed ID: 10638456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of potassium clavulanate/amoxicillin (CLAVAMOX) dry syrup in children with otitis media].
    Sugita R; Yamanaka N; Kudo F; Ito R; Kawai M; Ohwaki I; Asano S; Nagata T
    Jpn J Antibiot; 2007 Aug; 60(4):221-41. PubMed ID: 18018419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy in pediatrics sinusitis infections of cefditoren pivoxil granule therapy and its in vitro antibacterial activity against clinically isolated strains].
    Sugita R; Deguchi K; Fujimaki Y; Harada S; Shimizu K; Kimura S; Watanabe H; Komatsu N; Okano K; Naito M; Nomura T; Tanaka M; Yoshida Y; Tanaka H; Iwai N; Nakamura H
    Jpn J Antibiot; 1997 Aug; 50(8):727-37. PubMed ID: 9339399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Basic and clinical studies on cefditoren pivoxil in pediatric field].
    Motohiro T; Handa S; Yamada S; Oki S; Yoshinaga Y; Sasaki H; Aramaki M; Oda K; Sakata Y; Kato H
    Jpn J Antibiot; 1994 Apr; 47(4):409-27. PubMed ID: 8201769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibacterial activity of oral Cephems against various clinically isolated strains].
    Oshiro T; Fukutomi Y; Takayanagi M; Kusaba K; Nagasawa Z; Aoki Y; Nagayama A
    Jpn J Antibiot; 2003 Dec; 56(6):681-90. PubMed ID: 15007876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of clinical bacteriological efficacy of oral antibiotics using a mechanism-based pharmacokinetic-pharmacodynamics modeling.
    Matsumoto K; Sugano T; Sato N; Ida T; Shibasaki S
    Jpn J Antibiot; 2014 Feb; 67(1):33-47. PubMed ID: 24809207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic therapy against acute tonsillopharyngitis in children due to group A beta-hemolytic streptococci: comparison of clinical efficacy, the bactericidal effects, and effects on oral flora between cefditoren pivoxil for 5 days and amoxicillin for 10 days].
    Tsumura N; Nagai K; Hidaka H; Otsu Y; Tanaka Y; Ikezawa S; Honma S; Shindo S; Ubukata K
    Jpn J Antibiot; 2011 Jun; 64(3):179-90. PubMed ID: 21861309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibacterial activity of oral cephems against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/pharmacodynamics theory].
    Nakamura T; Takahashi H
    Jpn J Antibiot; 2004 Dec; 57(6):465-74. PubMed ID: 15747584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of nasopharyngeal bacterial flora. Second report. Variations in nasopharyngeal bacterial flora in children aged 6 years or younger when administered antimicrobial agents. Part 1.
    Konno M; Baba S; Mikawa H; Hara K; Matsumoto F; Kaga K; Nishimura T; Kobayashi T; Furuya N; Moriyama H; Okamoto Y; Furukawa M; Yamanaka N; Matsushima T; Yoshizawa Y; Kohno S; Kobayashi K; Morikawa A; Koizumi S; Sunakawa K; Inoue M; Ubukata K
    J Infect Chemother; 2006 Oct; 12(5):287-304. PubMed ID: 17109094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children.
    Leibovitz E; Piglansky L; Raiz S; Press J; Leiberman A; Dagan R
    Pediatr Infect Dis J; 2000 Nov; 19(11):1040-5. PubMed ID: 11099083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.